Cortisol Face and Cortisol Belly: A Borrowed Sign and a One-Percent Link.

Two self-diagnoses are doing the rounds: cortisol face and cortisol belly. Puffiness you can allegedly diagnose in the bathroom mirror, and a specific kind of stomach that stress supposedly builds. Whatever the age of the names, the pitch behind the belly one is more than twenty years old: a pill was being sold on it in national infomercials in 2003, and in 2004 the Federal Trade Commission charged its marketers with making false and unsubstantiated claims. [5]

The facial one is borrowed. Moon face is a real clinical sign — of Cushing’s syndrome. The usual cause of that is prescribed steroid medicine. [3] Otherwise it is a disease rare enough to be counted in new cases per million people a year: 1.8 to 3.2 in the counts one review collected from medical records, 2 to 8 by a later review’s estimate. [2] [7] The belly one rests on a real association, measured against waist size in 24 separate groups of people, that comes to about one percent of the story. [1]

Between them the two phrases draw about 44,000 Google searches a month in the United States (Google Ads figures for the year to June 2026, pulled 8 August 2026). The videos explaining how to fix yours often have a supplement underneath them: of the twelve we read, five linked to supplements sold under the presenter’s own brand, two of them named for cortisol, one of those with a discount code.

Moon face is real. It belongs to a prescription, or to a disease.

The puffy, rounded facial appearance being described is a genuine clinical sign. Doctors call it moon face, and it belongs to Cushing’s syndrome — what happens when the body is exposed for a long time to far too much cortisol, or to the steroid medicines that act like it. The Endocrine Society’s guideline for diagnosing it lists “facial fullness” among the features. [3]

By that guideline’s account the commonest cause is not a tumour, and it is not stress. It is prescribed steroid medicine: corticosteroids, the kind that act like cortisol (not the muscle-building kind), whether swallowed, inhaled, rubbed on or injected. How much it shows depends on the drug, the dose, the route and how long it has been taken. [3] If that is you and your face has changed, the change has a real cause and a real name, and it belongs in front of the doctor who prescribed the medicine. It is not a reason to stop taking anything on your own: coming off steroids is a medical matter in itself, which we cover in our verdict on cortisol detoxes.

The other kind, the one the body makes on its own, comes from a tumour on the pituitary gland, at the base of the brain, in 70% of cases by one review’s count. [2] It is a real illness. It raises the risk of dying, mostly from heart disease, and survival stays affected even after apparently successful treatment. [2] It is genuinely serious.

It is also this rare: where researchers went through medical records, they counted between 1.8 and 3.2 new cases per million people a year. [2] The lowest of those counts, New Zealand’s, left out the forms caused by cancers, and a 2023 review in JAMA puts the range wider, at 2 to 8. [7]

Per million. Per year. In a city of a million people, somewhere between two and eight of them will develop it in the course of a year. The counts were not all made the same way and do not all agree; what each one counted is on our page about high cortisol symptoms.

That is new cases. It is a different number from how many people are living with the diagnosis, and two of the studies that went through medical records counted both: 79 people per million in New Zealand, in a study of cases from 1960 to 2005, and 57 per million in western Sweden, from 2002 to 2017. [2] Roughly one person in 13,000 to 18,000.

So “cortisol face” takes a sign that belongs to a prescription or to a rare disease, detaches it from both, and offers it back to everybody as something ordinary stress has done to them. On its own, a full face does not single anybody out: the same guideline files facial fullness with the features that are common in the general population or do little to pick out the disease. [3] Nothing in the sources behind this page ties a puffy face to everyday stress.

Now the belly, where there is actually something

Here we have to be fair, because there is real evidence and we are not going to pretend otherwise.

Cortisol genuinely is associated with fat around the middle. And the evidence base is enormous: a meta-analysis pooling 146 cohorts and 34,342 people, measuring cortisol in hair — which captures months of exposure rather than one anxious morning. [1]

Pooled, the association came out positive on every measure they looked at: BMI (122 cohorts), waist circumference (24) and waist-to-hip ratio (16). [1] A cohort is one group of people studied together, and not every cohort found a link; the paper says so. But every pooled number pointed the same way.

Then you look at how big it is.

What a correlation of 0.10 looks like
1.00 — perfect. Knowing one tells you the other exactly.
0.50 — strong. One accounts for a quarter of the differences in the other.
0.30 — moderate. Worth building a model on.
0.18 — hair cortisone against waist size, across 7 cohorts.
0.11 — hair cortisol against waist size, across 24 cohorts.
0.10 — hair cortisol against BMI, across 122 cohorts.
0.00 — nothing at all.
van der Valk et al., Obesity Reviews 2022. The whole review: 146 cohorts, 34,342 people.

Consistent is not the same as large

A correlation of 0.10 is what they found between hair cortisol and BMI, pooled across 122 cohorts and 26,527 people. [1] Against waist size, which is the belly measure, it was 0.11, across 24 cohorts and 11,006 people. [1] The strongest relationship in the whole analysis — hair cortisone, the inactive form of cortisol, against waist size — reached 0.18, in 7 cohorts and 3,158 people. [1]

Square a correlation and you get the share of the variation it accounts for. At 0.10 or 0.11, that is about one percent. At 0.18 it is about three. So somewhere between ninety-seven and ninety-nine percent of why one person’s waist differs from another’s is something else entirely.

This is the distinction the whole page turns on, and it is worth carrying away for other topics too: a hundred and forty cohorts can show a link is real and, in the same table, show it is small. A huge study does not make a small number big. It just makes you confident the small number is correct.

“Small” is our word, and the researchers would only half agree with it. They call the BMI link a small effect of less clinical relevance, and the cortisone-and-waist link their largest and clinically relevant: a waist 4.3 inches (11.0 cm) bigger for every ten-fold step up in hair cortisone (their example is going from 1 to 10 picograms in a milligram of hair), in 6 cohorts and 3,102 people. [1] Both can be true. A correlation of 0.18 still leaves about ninety-seven percent of the difference between two waists to something else.

And nobody has shown which way the arrow points

One more detail, from the researchers’ own paper, that the sales pitch leaves out.

The pitch needs cortisol to be the cause. The researchers say it may be, and in the same sentence that they have not shown it: the pattern, they write, “may induce or aggravate obesity, although causality cannot be proven by our study”. [1] Their closing paragraph leaves both readings open. Higher long-term levels of the hormone, it says, “may contribute to or reflect” fat around the middle. [1]

Their data cannot settle it either way. Every study in the pool was cross-sectional, meaning everything was measured at one moment, so nothing in it can tell you which came first. [1] When the same group followed adults forward (about a thousand people in a Dutch study of depression and anxiety, over about three years), more hair cortisol went with a BMI rising 0.58% a year faster and more hair cortisone with a waist growing 0.84% a year faster, each for a ten-fold step up in the hormone. Neither hormone predicted the other measure, the waist result only just cleared the line researchers use for “probably not chance”, and the authors called the effects “relatively modest” and causality yet to be proven. [4]

So the researchers and the videos do not part company over which way the arrow might point. They part over what has been shown. The papers say unproven, and ask for longer studies. The videos say settled, and sell the fix.

What is actually being sold

On 8 August 2026 we ran one YouTube search, “cortisol belly how to fix”, and read the first twelve results as they came back. The eleven with cortisol in the title carried more than six million views between them; with the twelfth, past fourteen million. Two of the twelve descriptions linked to a supplement named for cortisol and sold under the presenter’s own brand, one of them with a discount code, and a third linked to the presenter’s own stress supplement. The newest of the twelve had gone up on 4 July 2026. The two most-watched cortisol titles were from 2014 and 2019.

We are not naming anybody, because the individuals are not the point and this site does not do that. The point is the shape: a real but one-percent association, plus a real but rare disease, combined into a condition you can be sold a cure for.

That measurement tells you how far the claim travels and what it sells. It tells you nothing about whether cortisol is doing anything to your face, and we are not using it that way.

And the pill has been sold before. In October 2004 the Federal Trade Commission announced charges against the marketers of a supplement called CortiSlim, for claiming “falsely and without substantiation” that it caused weight loss. By the FTC’s account its infomercials, on national television from August 2003, had promoted cortisol control as the answer for anyone wanting to lose weight, especially from the abdomen; the agency also began writing to more than 25 other sellers of cortisol products to say it knew of no competent and reliable scientific evidence for such claims. [5] By January 2007 the marketers had agreed to settle, giving up assets worth at least $12 million. The settlement orders, the FTC notes, are not admissions that the law was broken. [6]

The part we want you to actually take seriously

The kind of Cushing’s syndrome the body makes on its own is rare, but it is not imaginary, and one review of it calls early diagnosis and prompt treatment key to how patients fare in the long run. [2]

So this page is not telling you that facial puffiness never matters. If something about your face, your weight or your energy has genuinely changed and you cannot explain it — go and be looked at by a doctor, who can order the laboratory tests a mirror and a video cannot stand in for. One result does not settle it either: the guideline sends anyone whose first test comes back abnormal to a hormone specialist for a second. [3] What they look for is in our verdict on high cortisol symptoms.

What we are telling you is that the answer to that question is not a supplement, and the place to ask it is not a comments section.

The verdict

“Cortisol face” and “cortisol belly” as conditions you can spot in the mirror and reverse: Unsupported. The facial version borrows a clinical sign from Cushing’s syndrome: most often the work of prescribed steroid medicine, otherwise a disease newly diagnosed in a few people per million a year (1.8 to 3.2 in counts from medical records, among them New Zealand, 1960 to 2005, and western Sweden, 2002 to 2017; 2 to 8 by a 2023 review). The belly version rests on a real association that comes to between one and three percent of the story (waist size against hair cortisol in 24 cohorts, against hair cortisone in 7) — and whose direction the researchers say their own data cannot settle.

Stress is worth taking seriously. Just not as a diagnosis you give yourself, and not as a reason to buy anything.

Related: high cortisol symptoms · how to lower cortisol · cortisol detox · ashwagandha benefits · can exercise target belly fat · sleep hygiene · box breathing · all the habits we have checked

Sources
[1] van der Valk E, Abawi O, Mohseni M, Abdelmoumen A, Wester V, van der Voorn B, et al. Cross-sectional relation of long-term glucocorticoids in hair with anthropometric measurements and their possible determinants: a systematic review and meta-analysis. Obesity Reviews 2022;23(3):e13376. doi:10.1111/obr.13376
[2] Hakami OA, Ahmed S, Karavitaki N. Epidemiology and mortality of Cushing’s syndrome. Best Practice & Research Clinical Endocrinology & Metabolism 2021;35(1):101521. doi:10.1016/j.beem.2021.101521
[3] Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2008;93(5):1526–1540. doi:10.1210/jc.2008-0125
[4] van der Valk ES, van der Voorn B, Iyer AM, Mohseni M, Leenen PJM, Dik WA, et al. Hair cortisol, obesity and the immune system: results from a 3 year longitudinal study. Psychoneuroendocrinology 2021;134:105422. doi:10.1016/j.psyneuen.2021.105422
[5] US Federal Trade Commission, 5 October 2004. “FTC Targets Products Claiming to Affect the Stress Hormone Cortisol.” Complaint against the marketers of CortiSlim and CortiStress, filed 30 September 2004; warning letters to more than 25 other sellers. ftc.gov
[6] US Federal Trade Commission, 4 January 2007. “Federal Trade Commission Reaches New Years Resolutions with Four Major Weight-Control Pill Marketers.” CortiSlim and CortiStress settlements, assets worth at least $12 million. ftc.gov
[7] Reincke M, Fleseriu M. Cushing syndrome: a review. JAMA 2023;330(2):170–181. Read as its published summary; the full text is behind a subscription. doi:10.1001/jama.2023.11305
Correction · 30 September 2026

Three things this page said about its own sources were wrong, and were corrected on 30 September 2026 after an independent editorial review. It said the researchers behind the belly-fat analysis suspected that fat drives cortisol rather than the other way round. Their paper says the pattern may induce or aggravate obesity, that a study measuring everything at one moment cannot prove cause, and that higher long-term levels may contribute to or reflect fat around the middle; the section, the evidence panel and the verdict now say that, and cite the same group’s three-year follow-up. The headline, the search snippet and the verdict said Cushing’s syndrome “affects” three people in a million. That figure is new cases per year (1.8 to 3.2 per million, in New Zealand and western Sweden); the same two studies count 79 and 57 people per million living with the diagnosis. And the page credited the belly link, and the figure 0.10, to 146 cohorts. 146 is the size of the whole review; 0.10 is hair cortisol against BMI in 122 of them, and waist size was measured against hair cortisol in 24, at 0.11.

Also changed: the page now says what it had left out, that the commonest cause of a moon face is prescribed steroid medicine, not a tumour, and it cites the clinical guideline for the sign itself, which the epidemiology review we had cited never mentions. The funding row said funding was not stated; the main analysis names a non-profit foundation and a Dutch public grant and declares no conflicts. The video count now says what we did (one YouTube search on 8 August 2026, twelve results) and counts two own-brand cortisol supplements where it had said “several”; “forty-four thousand people” was about 44,000 US Google searches; and the page now reports that the Federal Trade Commission charged the marketers of a cortisol weight-loss pill in 2004. A rung on the page’s chart, “height and shoe size” at 0.50, had no source and is gone. The headline changed with the figure in it. The rating is unchanged.

Correction · 30 September 2026

A second correction on 30 September 2026. This page gave the rate of new Cushing’s syndrome cases as 1.8 to 3.2 per million people a year, flatly and in bold. That is the range of three counts in a 2021 review, each made by going through medical records, and the lowest of them, New Zealand’s, left out the forms caused by cancers. A 2023 review in JAMA, which we have read only as its published summary, puts the range at 2 to 8. The page now says which figure is which, cites the second review, and points to our page on high cortisol symptoms, where the counts that disagree are set out one by one. The page also said a doctor “can order a test that settles it”. The guideline it cites sends anyone with an abnormal first result for a second test, and the sentence now says so. Both points came up while that neighbouring page was being corrected the same day. The rating is unchanged.